Anti-HCAR2 antibody (100-200) [S4625RM] (STJ11104625)

SPECIFICATIONS
ClonalityMonoclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG
STJ11104625
๐Ÿšš Free UK Delivery on orders over ยฃ150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRabbit monoclonal Hydroxycarboxylic Acid Receptor 2 (100-200) antibody for use in WB and ELISA in mouse and rat samples. Datasheet included with dilution recommendations, and related reagents.
ApplicationsWB/ELISA
HostRabbit
ReactivityMouse/Rat
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ClonalityMonoclonal
Clone IDS4625RM
IsotypeIgG
ConjugationUnconjugated
ConcentrationLot specific
PurificationAffinity purification
Dilution RangeWB:1:1000-1:5000
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
FormulationPBS with 0.05% Proclin300, 0.05% BSA, 50% Glycerol, pH 7.3.
Storage InstructionStore at-20ยฐC for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.

Target Information

Gene SymbolHCAR2
Gene ID338442
Uniprot IDHCAR2_HUMAN
Immunogen Region100-200
Immunogen SequenceCRLMLFMLAMNRQGSIIFLT VVAVDRYFRVVHPHHALNKI SNRTAAIISCLLWGITIGLT VHLLKKKMPIQNGGANLCSS FSICHTFQWHEAMFLLEFFL P
SpecificityA synthetic peptide corresponding to a sequence within amino acids 100-200 of human GPR109A/HM74A/HCAR2 (NP_808219.1).

Additional Info

Tissue Specificity Expression largely restricted to adipose tissue and spleen. Expressed on mature neutrophils but not on immature neutrophils or eosinophils.
Function Acts as a high affinity receptor for both nicotinic acid (also known as niacin) and (D)-beta-hydroxybutyrate and mediates increased adiponectin secretion and decreased lipolysis through G(i)-protein-mediated inhibition of adenylyl cyclase. This pharmacological effect requires nicotinic acid doses that are much higher than those provided by a normal diet. Mediates nicotinic acid-induced apoptosis in mature neutrophils. Receptor activation by nicotinic acid results in reduced cAMP levels which may affect activity of cAMP-dependent protein kinase A and phosphorylation of target proteins, leading to neutrophil apoptosis. The rank order of potency for the displacement of nicotinic acid binding is 5-methyl pyrazole-3-carboxylic acid = pyridine-3-acetic acid > acifran > 5-methyl nicotinic acid = acipimox >> nicotinuric acid = nicotinamide.
Protein Name Hydroxycarboxylic Acid Receptor 2
G-Protein Coupled Receptor 109a
G-Protein Coupled Receptor Hm74a
Niacin Receptor 1
Nicotinic Acid Receptor
Database Links Reactome: R-HSA-3296197
Reactome: R-HSA-373076
Reactome: R-HSA-418594
Cellular Localisation Cell Membrane
Multi-Pass Membrane Protein
Alternative Antibody Names Anti-Hydroxycarboxylic Acid Receptor 2 antibody
Anti-G-Protein Coupled Receptor 109a antibody
Anti-G-Protein Coupled Receptor Hm74a antibody
Anti-Niacin Receptor 1 antibody
Anti-Nicotinic Acid Receptor antibody
Anti-HCAR2 antibody
Anti-GPR109A antibody
Anti-HCA2 antibody
Anti-HM74A antibody
Anti-NIACR1 antibody

Information sourced from Uniprot.org

Citations

Product Review